Bank of New York Mellon’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bank of New York Mellon’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-123,045	Closed	-$54.4K	–	4549
2023 Q1	$54.4K	Hold	123,045	–	–	﹤0.01%	4183
2022 Q4	$27K	Sell	123,045 -907	-0.7%	-$271	﹤0.01%	4319
2022 Q3	$45K	Hold	123,952	–	–	﹤0.01%	4344
2022 Q2	$81K	Sell	123,952 -798	-0.6%	-$530	﹤0.01%	4273
2022 Q1	$102K	Buy	+124,750	New	+$116K	﹤0.01%	4403
2021 Q3	–	Sell	-14,484	Closed	-$43K	–	4615
2021 Q2	$43K	Sell	14,484 -50,047	-78%	-$174K	﹤0.01%	4346
2021 Q1	$227K	Sell	64,531 -599	-0.9%	-$3.33K	﹤0.01%	4013
2020 Q4	$309K	Buy	65,130 +16,072	+33%	+$83K	﹤0.01%	3818
2020 Q3	$238K	Sell	49,058 -1,928	-4%	-$9.13K	﹤0.01%	3789
2020 Q2	$166K	Buy	+50,986	New	+$484K	﹤0.01%	3841

Other funds holding CEMI

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of New York Mellon's CEMI Position: Q2 2023 in Review

Bank of New York Mellon sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 123,045 shares — an estimated $54.4K sold.

Bank of New York Mellon first reported a position in CEMI in Q2 2020 and held it in 10 quarters. The position peaked at $309K in Q4 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

Bank of New York Mellon reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
Bank of New York Mellon sold 123,045 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $54.4K.
Bank of New York Mellon first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 10 quarters.
Bank of New York Mellon's Chembio diagnostics, Inc. position peaked at $309K in Q4 2020.
1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.